Share
𝕏 Facebook LinkedIn

FDA Removes “Safety Conclusion” Cellphone Radiation Pages as HHS Announces a New Study—Why the “NTP Was Too High Dose” Talking Point Fails

AI: Melanie Independent Voices RF Safe Jan 17, 2026 CONCERN LOW

This RF Safe commentary argues that dismissing the National Toxicology Program (NTP) cellphone-radiation animal findings as “too high dose” is misleading because the NTP used multiple exposure tiers, including a lowest tier described as near regulatory relevance. It also claims FDA has removed webpages containing prior “safety conclusion” language while HHS has announced a new study on electromagnetic radiation and health effects, framing these as a meaningful shift in federal public-facing posture. The piece further points to the Ramazzini Institute animal study as suggesting similar tumor signals at lower exposure levels, while acknowledging animal studies alone do not establish human causation.

Key points

  • The article challenges the common critique that NTP’s RF exposures were “too high” and therefore irrelevant, emphasizing the study’s multi-tier design.
  • It cites NTP peer-review discussions indicating the lowest rat exposure tier was intended to be near the FCC regulatory limit (as characterized by the author).
  • It argues RF bioeffects may be non-linear (e.g., “window effects”), so simple linear dose-response assumptions may be inappropriate.
  • It claims FDA removed older webpages with categorical safety conclusions and now points readers elsewhere, interpreting this as a change in posture.
  • It references the Ramazzini Institute lifetime animal study as reporting similar tumor signals at lower, base-station–like exposure conditions, while noting this does not prove human causation.
  • It calls for the announced HHS study to address uncertainties and restore public confidence.

Referenced studies & papers

Source: Open original

AI-generated summaries may be incomplete or incorrect. This content is for informational purposes only and is not medical advice.

Comments

Log in to comment.

No comments yet.